OBJECTIVE: Existing scoring systems for the diagnosis of group A streptococcus pharyngitis are insensitive or inapplicable in low-resources settings. Bacterial cultures and rapid tests can allow for antibiotic prescription abstention in high-income regions. These techniques are not feasible in many low-resources settings, and antibiotics often are prescribed for any pharyngitis episode. However, judicious antibiotics prescription in the community also is of concern in low-income countries. The objective of this study was to develop a clinical decision rule that allows for the reduction of empirical antibiotic therapy for children with pharyngitis in low-resources settings by identifying non-group A streptococcus pharyngitis. PATIENTS AND METHODS: We prospectively included children with pharyngitis in 3 public hospitals of Brazil during 9 months in 2004. We filled out clinical questionnaires and performed throat swabs. Bilateral chi2 (2-tailed test) and multivariate analysis were used to determine score categories. The outcome measures were sensitivity, specificity, positive likelihood ratio, and posttest probability of non-group A streptococcus infection with the clinical approach as compared with throat culture. RESULTS: A total of 163 of the 220 children had non-group A streptococcus pharyngitis (negative culture). We established a 3-questions decision rule (age and viral and bacterial signs) with 3 possible answers. The use of this score would prevent 41% to 55% of unnecessary antimicrobial prescriptions. The specificity of the score for non-group A streptococcus pharyngitis was >84%. CONCLUSION: Such a clinical decision rule could be helpful to reduce significantly unnecessary antibiotic prescriptions for pharyngitis in children in low-resources settings.
OBJECTIVE: Existing scoring systems for the diagnosis of group A streptococcuspharyngitis are insensitive or inapplicable in low-resources settings. Bacterial cultures and rapid tests can allow for antibiotic prescription abstention in high-income regions. These techniques are not feasible in many low-resources settings, and antibiotics often are prescribed for any pharyngitis episode. However, judicious antibiotics prescription in the community also is of concern in low-income countries. The objective of this study was to develop a clinical decision rule that allows for the reduction of empirical antibiotic therapy for children with pharyngitis in low-resources settings by identifying non-group A streptococcuspharyngitis. PATIENTS AND METHODS: We prospectively included children with pharyngitis in 3 public hospitals of Brazil during 9 months in 2004. We filled out clinical questionnaires and performed throat swabs. Bilateral chi2 (2-tailed test) and multivariate analysis were used to determine score categories. The outcome measures were sensitivity, specificity, positive likelihood ratio, and posttest probability of non-group A streptococcus infection with the clinical approach as compared with throat culture. RESULTS: A total of 163 of the 220 children had non-group A streptococcuspharyngitis (negative culture). We established a 3-questions decision rule (age and viral and bacterial signs) with 3 possible answers. The use of this score would prevent 41% to 55% of unnecessary antimicrobial prescriptions. The specificity of the score for non-group A streptococcuspharyngitis was >84%. CONCLUSION: Such a clinical decision rule could be helpful to reduce significantly unnecessary antibiotic prescriptions for pharyngitis in children in low-resources settings.
Authors: Milagritos D Tapia; Samba O Sow; Boubou Tamboura; Mahamadou M Keita; Abdoulaye Berthe; Mariam Samake; James P Nataro; Uma O Onwuchekwa; Thomas A Penfound; William Blackwelder; James B Dale; Karen L Kotloff Journal: Pediatr Infect Dis J Date: 2015-05 Impact factor: 2.129
Authors: Josta de Jong; Paul B van den Berg; Tjalling W de Vries; Lolkje T W de Jong-van den Berg Journal: Eur J Clin Pharmacol Date: 2008-06-18 Impact factor: 2.953
Authors: Eileen M Dunne; Julia L Marshall; Ciara A Baker; Jayne Manning; Gena Gonis; Margaret H Danchin; Pierre R Smeesters; Catherine Satzke; Andrew C Steer Journal: BMC Infect Dis Date: 2013-07-11 Impact factor: 3.090
Authors: Pierre Robert Smeesters; Anne Vergison; Dioclécio Campos; Eurico de Aguiar; Veronique Yvette Miendje Deyi; Laurence Van Melderen Journal: PLoS One Date: 2006-12-20 Impact factor: 3.240
Authors: Aurelino Rocha Barbosa Júnior; Cláudia Di Lorenzo Oliveira; Maria Jussara Fernandes Fontes; Laura Maria de Lima Bezário Facury Lasmar; Paulo Augusto Moreira Camargos Journal: Rev Paul Pediatr Date: 2014-12
Authors: Timothy S Uphoff; Blake W Buchan; Nathan A Ledeboer; Paul A Granato; Judy A Daly; Tara N Marti Journal: J Clin Microbiol Date: 2016-06-29 Impact factor: 5.948
Authors: Mustafa Kolukirik; Mesut Yılmaz; Orhan Ince; Canan Ketre; Ayşe Istanbullu Tosun; Bahar K Ince Journal: Ann Clin Microbiol Antimicrob Date: 2016-08-08 Impact factor: 3.944